MD Anderson Cancer Center’s Strategic Industry Ventures (Houston). Through collaborations with faculty and working with the health system’s Office of Technology Commercialization, MD Anderson’s Strategic Industry Ventures seeks to bring new drugs, diagnostics, devices and information solutions to market to benefit cancer patients. The OTC also looks for viable technologies to turn into startups. Since 1987 the office has played a part in creating 11 affiliated companies that have raised more than $300 million. Some of SIV’s partner companies include Abbvie, Amgen and Pfizer
| ← Previous | Next → |
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
